OR WAIT 15 SECS
West Pharmaceutical Services will be showcasing various new pharmaceutical containment and closure offerings at Pharmapack from Feb. 5–6 in Paris, France.
West Pharmaceutical Services, an injectable drug administration company based in Exton, PA, announced it will be showcasing various new pharmaceutical containment and closure offerings at Pharmapack from Feb. 5–6 in Paris, France.
According to a company press release, the new products include:
The company will also host two presentations during the conference. Fran DeGrazio, vice-president, Scientific Affairs and Technical Services at West, will present on “Understanding the Complexities of Delivering a Biologic Drug to the Market” during the main Pharmapack session on biologics on Feb. 6 at 10:05 a.m. CEST, and Nico Brandes, director, Market Development, Innovation, and Technology at West will host a Learning Lab session entitled, “Design with the End in Mind: Patient-Centric Innovations in Containment and Delivery,” on Feb. 6 at 11:30 a.m. CEST.
“West’s priority is to help customers simplify their journey, whether through new products or by helping mitigate risks in the drug development process to accelerate speed to market in today’s ever-evolving, complex industry and global regulatory environment,” said DeGrazio in the company press release. “We have deep knowledge of navigating the nuances of biologic drugs and delivery systems even at the earliest stages, including quality systems, design controls, and risk management frameworks. By keeping a lens on the unique interface between a drug, its primary package and device, we support our customers with smart integrated solutions from end to end that help them meet, if not exceed, industry standards.”